SCHEMBL2963377

SCHEMBL2963377

CC1=CCc2cc(Br)cc(-c3ccccc3)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
ESR2 Q92731 1/20 0.35
ALDH1A1 P00352 5/20 0.33
MAPK1 P28482 2/20 0.33
HDAC7 Q8WUI4 1/20 0.33
PRNP P04156 1/20 0.31
PPARG P37231 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
NR2E3 Q9Y5X4 1/20 0.31
NCOR2 Q9Y618 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
GABRA1 P14867 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA2 P47869 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2964358 0.87 ALDH1A1 (0.43) ESR2ALDH1A1MEN1MAPTKMT2A
SCHEMBL2956763 0.78 DHFR (0.35) ALDH1A1MAOBALOX5CYP2A6
SCHEMBL2967550 0.78 AKR1C3 (0.33) AKR1C3AKR1C2AKR1C1PTGDR2MAOB
SCHEMBL2974756 0.78 RAB9A (0.37) ALDH1A1MAPK1MAPTSMN1; SMN2
SCHEMBL2975302 0.77 CHEK1 (0.32) MAOB
SCHEMBL2966230 0.77 AKR1C3 (0.39) AKR1C3AKR1C2AKR1C1ESR2ALDH1A1
SCHEMBL2963510 0.75 MEN1 (0.41) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL2963883 0.75 ALDH1A1 (0.34) ESR2ALDH1A1MAPK1HDAC7CYP2A6
SCHEMBL2962460 0.75 CRHBP (0.43) AKR1C3AKR1C2AKR1C1ALDH1A1MAPK1
SCHEMBL2974752 0.74 NR1H2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 AKR1C3 3611/4885AKR1C2 3868/4885AKR1C1 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.